Evidence for waning of latency in a cohort study of tuberculosis

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Wiker, Harald G ^a,b   Mustafa, Tehmina ^a   Bjune, Gunnar A ^c   Harboe, Morten ^c  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE REGISTRY; DISEASE TRANSMISSION; FEMALE; GROUPS BY AGE; HUMAN; INFANT; INFECTION RATE; INFECTION RISK; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NORWAY; PRESCHOOL CHILD; SCHOOL CHILD; TUBERCULIN TEST; AGE; MIDDLE AGED; RECURRENT DISEASE;

ADULT; AGE FACTORS; AGED; COHORT STUDIES; FEMALE; HUMANS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; NORWAY; RECURRENCE; YOUNG ADULT;

EID: 77649313828     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-37     Document Type: Article

References (31)

1. Sterling TR. New approaches to the treatment of latent tuberculosis. Semin Respir Crit Care Med 2008, 29:532-541. 10.1055/s-0028-1085704, 18810686.
2. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc 1970, 26:28-106.
3. Parrish NM, Dick JD, Bishai WR. Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol 1998, 6:107-112. 10.1016/S0966-842X(98)01216-5, 9582936.
4. Pai M, O'Brien R. New diagnostics for latent and active tuberculosis: state of the art and future prospects. Semin Respir Crit Care Med 2008, 29:560-568. 10.1055/s-0028-1085707, 18810689.
5. Opie EL, Aronson JD. Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculous lesions. Arch Pathol Lab Med 1927, 4:1-21.
6. Balasubramanian V, Wiegeshaus EH, Taylor BT, Smith DW. Pathogenesis of tuberculosis: pathway to apical localization. Tuber Lung Dis 1994, 75:168-178. 10.1016/0962-8479(94)90002-7, 7919306.
7. Hernandez-Pando R, Jeyanathan M, Mengistu G, Aguilar D, Orozco H, Harboe M, Rook GAW, Bjune G. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet 2000, 356:2133-2138. 10.1016/S0140-6736(00)03493-0, 11191539.
8. Lillebaek T, Dirksen A, Baess I, Strunge B, Thomsen V. Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J Infect Dis 2002, 185:401-404. 10.1086/338342, 11807725.
9. Lillebaek T, Dirksen A, Vynnycky E, Baess I, Thomsen V, Andersen AB. Stability of DNA patterns and evidence of Mycobacterium tuberculosis reactivation occurring decades after the initial infection. J Infect Dis 2003, 188:1032-1039. 10.1086/378240, 14513424.
10. Lin MY, Ottenhoff TH. Host-pathogen interactions in latent Mycobacterium tuberculosis infection: identification of new targets for tuberculosis intervention. Endocr Metab Immune Disord Drug Targets 2008, 8:15-29. 10.2174/187153008783928398, 18393920.
11. Borgdorff MW, Werf MJ, de Haas PE, Kremer K, van Soolingen D. Tuberculosis elimination in the Netherlands. Emerg Infect Dis 2005, 11:597-602.
12. Bjartveit K. [Article in Norwegian][Situation of tuberculosis in Norway]. Tidsskr Nor Laegeforen 1975, 95:1049-1055.
13. Dahl E, Backer J. [Article in Norwegian][Tuberculosis in Oslo during the war]. Nor Mag Laegevid 1945, 108:2305-2313.
14. Dahle UR, Sandven P, Heldal E, Caugant DA. Continued low rates of transmission of Mycobacterium tuberculosis in Norway. J Clin Microbiol 2003, 41:2968-2973. 10.1128/JCM.41.7.2968-2973.2003, 165220, 12843028.
15. Dahle UR, Sandven P, Heldal E, Caugant DA. Molecular epidemiology of Mycobacterium tuberculosis in Norway. J Clin Microbiol 2001, 39:1802-1807. 10.1128/JCM.39.5.1802-1807.2001, 88029, 11325994.
16. Bandera A, Gori A, Catozzi L, Degli EA, Marchetti G, Molteni C, Ferrario G, Codecasa L, Penati V, Mateelli A, Franzetti F. Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis. J Clin Microbiol 2001, 39:2213-2218. 10.1128/JCM.39.6.2213-2218.2001, 88113, 11376059.
17. Andvord KF. [Original article in Norwegian][What can we learn by following the development of tuberculosis from one generation to another?]. Nor Mag Laegevid 1930, 91:642-660.
18. Andvord KF. [Translation of original article published in 1930][What can we learn by following the development of tuberculosis from one generation to another?]. Int J Tuberc Lung Dis 2002, 6:562-568.
19. Blomberg B, Rieder HL, Enarson DA. Kristian Andvord's impact on the understanding of tuberculosis epidemiology. Int J Tuberc Lung Dis 2002, 6:557-559.
20. Haider T, Tverdal A. [Article in Norwegian][Prevalence of tuberculosis infections]. Tidsskr Nor Laegeforen 1982, 102:1065-1068.
21. Sandberg HK. [Article in Norwegian][Register of tuberculin test results and decrease in tuberculosis; indications for continuing present control procedures]. Tidsskr Nor Laegeforen 1954, 74:317-322.
22. Comstock GW. Frost revisited: the modern epidemiology of tuberculosis. Am J Epidemiol 1975, 101:363-382.
23. France AM, Cave MD, Bates JH, Foxman B, Chu T, Yana Z. What's driving the decline in tuberculosis in Arkansas? A molecular epidemiologic analysis of tuberculosis trends in a rural, low-incidence population, 1997-2003. Am J Epidemiol 2007, 166:662-671. 10.1093/aje/kwm135, 17625223.
24. Grzybowski S, Allen EA. The challenge of tuberculosis in decline. A study on the epidemiology of tuberculosis in Ontario, Canada. Am Rev Respir Dis 1964, 90:707-720.
25. Mori T, Harada N, Higuchi K, Sekiya Y, Uchimura K, Shimao T. Waning of the specific interferon-gamma response after years of tuberculosis infection. Int J Tuberc Lung Dis 2007, 11:1021-1025.
26. Tocque K, Bellis MA, Tam CM, Chan SL, Syed Q, Remmington T, Davies PD. Long-term trends in tuberculosis. Comparison of age-cohort data between Hong Kong and England and Wales. Am J Respir Crit Care Med 1998, 158:484-488.
27. Fine PE, Small PM. Exogenous reinfection in tuberculosis. N Engl J Med 1999, 341:1226-1227. 10.1056/NEJM199910143411609, 10519901.
28. van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Enarson DA, Beyers N, van Elden PD. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999, 341:1174-1179. 10.1056/NEJM199910143411602, 10519895.
29. Warren RM, Victor TC, Streicher EM, Richardson M, Beyers N, Gey van Pittius NC, van Elden PD. Patients with active tuberculosis often have different strains in the same sputum specimen. Am J Respir Crit Care Med 2004, 169:610-614. 10.1164/rccm.200305-714OC, 14701710.
30. Victor TC, Streicher EM, Kewley C, Jordaan AM, Spuy GD, Bosman M, Louw H, Murray M, Young D, van Helden PD, Warren RM. Spread of an emerging Mycobacterium tuberculosis drug-resistant strain in the western Cape of South Africa. Int J Tuberc Lung Dis 2007, 11:195-201.
31. Mlambo CK, Warren RM, Poswa X, Victor TC, Duse AG, Marais E. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. Int J Tuberc Lung Dis 2008, 12:99-104.